CEDAR
CEDAR catalogs cancer-associated epitopes and associated receptor information to enable analysis of adaptive T cell and B cell responses and molecular characterization of cancer antigens.
Key Features:
- Cancer epitope cataloging: Systematic compilation of epitopes specifically in the context of cancer.
- Adaptive immune scope: Records epitopes recognized by adaptive T cell and B cell immune responses.
- Receptor information: Includes associated receptor data linked to epitopes.
- Molecular characterization: Stores detailed molecular characteristics of cancer epitopes.
- Metadata annotation: Captures relevant metadata for epitopes and associated entries.
- Literature curation: Entries are compiled from the scientific literature.
- IEDB complementarity: Focuses on cancer-related epitopes complementary to the Immune Epitope Database (IEDB) scope.
Scientific Applications:
- Immunological characterization: Analysis of naturally occurring immune responses to tumor-derived antigens.
- Cancer immunopathology studies: Investigation of immune mechanisms and pathology in cancer.
- Therapeutic development: Informing design and evaluation of cancer immunotherapies and therapeutic interventions.
- Prophylactic planning: Supporting planning of prophylactic measures related to cancer antigens.
- Comparative epitope analysis: Enabling comparisons between cancer epitope data and IEDB datasets.
Methodology:
Curated compilation from the scientific literature with annotation of epitope entries including associated receptor information, molecular characteristics, and relevant metadata.
Topics
Details
- License:
- Other
- Cost:
- Free of charge
- Tool Type:
- web application
- Operating Systems:
- Mac, Linux, Windows
- Added:
- 12/23/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Koşaloğlu-Yalçın Z, Blazeska N, Vita R, Carter H, Nielsen M, Schoenberger S, Sette A, Peters B. The Cancer Epitope Database and Analysis Resource (CEDAR). Nucleic Acids Research. 2022;51(D1):D845-D852. doi:10.1093/nar/gkac902. PMID:36250634. PMCID:PMC9825495.
DOI: 10.1093/nar/gkac902
PMID: 36250634
PMCID: PMC9825495
Funding: - National Institutes of Health: 75N93019C00001, U24CA248138